Locally Advanced Pancreatic Cancer Recruiting Phase 3 Trials for Irinotecan (DB00762)

Also known as: Pancreatic Carcinoma Stage II / Locally advanced Pancreatic cancer

IndicationStatusPhase
DBCOND0040768 (Locally Advanced Pancreatic Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03468335Second-line Therapy With Nal-IRI After Failure Gemcitabine/Nab-paclitaxel in Advanced Pancreatic Cancer - Predictive Role of 1st-line TherapyTreatment